StockKit ResearchEQUITY RESEARCH BRIEF
603259 · CN · Fresh
Generated 2026-09-12 13:41 UTC
药明康德
603259 · CN
¥151.24
-2.11%
Technical posture
Neutral
Strategy score
48 / 100
Trend
bear
Data confidence
Medium
Research view
603259 Research Preview
1. Bottom line
- 603259 (药明康德) is trading at 151.24, with a current daily move of -2.11%.
- The StockKit strategy score is 48/100, creating a neutral research posture with mixed alignment (ma5 > ma10 > ma20 > ma60).
- The most important near-term watch zone is support at 148.64 and resistance at 168.17; price is +1.72% from support and +11.19% from resistance.
2. Key data snapshot
| Item | Reading | Interpretation |
|---|---:|---|
| Current price | 151.24 | Daily move -2.11% |
| Strategy score | 48/100 | Hold, trend: bear |
| MA structure | Mixed alignment (MA5 > MA10 > MA20 > MA60) | The short-term moving average is below the medium-term moving average, so the trend still needs repair. |
| RSI14 | 48.13 | Neutral momentum |
| MACD | -1.90 histogram | Bearish MACD configuration |
| Support / resistance | 148.64 / 168.17 | Watch these levels for confirmation or failure |
| 30-session range | 126.15 / 173.60 | Price sits at +52.88% of the range |
| Volume check | -29.74% vs 20D avg | Confirmation quality depends on volume follow-through |
| ATR14 / price | +3.07% | Proxy for short-term volatility risk |
3. Technical indicator panel
- Trend: The short-term moving average is below the medium-term moving average, so the trend still needs repair.
- Momentum: RSI14 is not giving an extreme signal, so confirmation from price structure matters more than momentum alone.
- MACD: histogram is -1.90, while MACD line / signal are 2.19 / 4.10.
- KDJ: K / D / J are 33.97 / 36.45 / 29.02; KDJ soft or still repairing.
- Bollinger: Near lower band (13% of band); upper / middle / lower are 168.17 / 158.41 / 148.64.
- ATR / OBV / CCI: ATR14 is 4.65 (+3.07% of price), OBV slope is -8.05%, and CCI20 is -107.23.
- Levels: estimated support / resistance are 148.64 / 168.17; recent 30-session range is 126.15 / 173.60.
4. Valuation matrix
| Axis | Reading | Source | Confidence |
|---|---|---|---|
| PE | 22.57 | AkShare THS financial abstract | Medium |
| PB | 5.41 | AkShare THS financial abstract | Medium |
| PEG proxy | 1.25 | StockKit scenario model | Medium |
| StockKit fair value range | Bear CNY 134.33 / Base CNY 184.73 / Bull CNY 232.1 | StockKit DCF scenario model | Medium |
| Base fair-value gap | +22.1% | StockKit DCF scenario model | Medium |
| 5Y growth forecast | Bear +10.00% / Base +18.00% / Bull +24.00% | StockKit scenario model | Medium |
| Revenue | CNY 45.46B | AkShare THS financial abstract | Medium |
| Net income | CNY 19.15B | AkShare THS financial abstract | Medium |
| EPS | 6.7 | AkShare THS financial abstract | Medium |
| Book value per share | 27.93 | AkShare THS financial abstract | Medium |
| Gross margin | +53.91% | AkShare THS financial abstract | Medium |
| Net margin | +38.50% | AkShare THS financial abstract | Medium |
Notes: - AkShare report period used for income data: 2025-12-31. - PEG and fair-value range are StockKit scenario outputs computed from public financial history; they are not analyst consensus targets.
5. News and catalyst timeline
1. WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion - PRNewswire
2. 藥明康德出售藥明合聯4.23%股權，套現39.2億港元 - Yahoo Entertainment
6. Sentiment radar
2 recent headlines available; no provider-level sentiment score was supplied.
| Source | Status | Reading | Confidence |
|---|---|---|---|
| NewsAPI headline coverage | 2 headlines | PRNewswire x1, Yahoo Entertainment x1 | Low |
| Social sentiment | Not connected | No social sentiment conclusion is drawn | Low |
Notes: - No provider sentiment series was returned for this symbol.
7. Scenario framework
| Scenario | Trigger condition | Confirmation signal | Invalidation signal |
|---|---|---|---|
| Base case | Price remains between 148.64 and 168.17 | Strategy score stays near 48/100 and RSI avoids extremes | Close below support or a rapid score deterioration |
| Upside case | Price clears 168.17 | Improving MACD histogram and volume above 20D average | Failed breakout back below resistance |
| Downside case | Price breaks 148.64 | RSI weakens and MACD remains negative | Quick recovery back above support |
8. Risk matrix
| Risk | Evidence | Trigger | Monitoring action |
|---|---|---|---|
| Technical failure | Support at 148.64 anchors the current setup | Close below support | Reassess trend and reduce confidence in base case |
| Momentum exhaustion | Neutral momentum; MACD state: Bearish MACD configuration | RSI extension or MACD rollover | Watch next 1-3 closes and histogram direction |
| Volatility expansion | ATR14 / price is +3.07% | Wide ranges without follow-through | Require confirmation before trusting a directional move |
| News/data gap | 2 current news items available | New headline or missing catalyst context | Refresh news before relying on stale views |
9. Seven-day watch checklist
- First watch: whether price respects 148.64 or starts accepting below it.
- Breakout watch: whether price can clear 168.17 with volume confirmation above the 20-session average.
- Momentum watch: whether RSI14 stays constructive without moving into an exhaustion zone.
- Risk watch: whether fresh news changes the catalyst picture.
Strategy cross-check
| Strategy | Score | Signal | Basis |
|---|---|---|---|
| MA交叉 | 30/100 | Sell | MA5<MA20死叉 |
| MACD背离 | 40/100 | Hold | MACD死叉，MACD在零轴上方，动能减弱 |
| RSI极值 | 50/100 | Hold | RSI14=48中性 |
| 布林带 | 65/100 | Buy | 接近下轨，可能反弹，带宽扩张中 |
Information-use note
StockKit provides market research tools for informational and educational use. The output does not constitute personalized investment advice or a recommendation to buy, sell, or hold any security.
Strategy factors
MA交叉Weak
30
MA5<MA20死叉
MACD背离Neutral
40
MACD死叉，MACD在零轴上方，动能减弱
RSI极值Neutral
50
RSI14=48中性
布林带Constructive
65
接近下轨，可能反弹，带宽扩张中
量价关系Neutral
55
缩量回调，可能企稳
News & catalyst inputs
WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion
PRNewswire · 2026-08-31
藥明康德出售藥明合聯4.23%股權，套現39.2億港元
Yahoo Entertainment · 2026-08-27
Research boundary
StockKit organizes market data and model output for research workflows. It does not provide personalized advice or trade instructions. Verify important information with primary sources before any investment decision.
Disclaimer.This brief is generated by StockKit AI from public market data and algorithmic models for informational research only. It is not investment advice, an offer, or a solicitation, and it does not provide buy, sell, or hold ratings, price targets, stop-loss levels, or position sizing. “Watch levels” and “scenarios” describe observable conditions in the supplied data, not instructions. Verify all information with primary sources before any investment decision.